{
    "ticker": "BHC",
    "name": "Bausch Health Companies Inc.",
    "description": "Bausch Health Companies Inc. is a global company dedicated to advancing the science of health. With a history that dates back over 160 years, Bausch Health operates in the pharmaceutical and medical device sectors, focusing on the development, manufacturing, and commercialization of innovative products. The company provides a wide range of healthcare solutions across several therapeutic areas, including dermatology, ophthalmology, and gastrointestinal health. Bausch Health is recognized for its commitment to addressing the unmet medical needs of patients worldwide, offering products such as contact lenses, surgical instruments, and specialty pharmaceuticals. The company has made significant investments in research and development to create novel therapies and enhance patient outcomes. Its mission is to improve people's lives with its innovative products while maintaining a strong ethical foundation and commitment to corporate responsibility. Bausch Health is headquartered in Laval, Quebec, Canada, and serves healthcare professionals and patients across the globe.",
    "industry": [
        "Pharmaceuticals",
        "Medical Devices"
    ],
    "headquarters": "Laval, Quebec, Canada",
    "founded": "2013",
    "website": "https://www.bauschhealth.com",
    "ceo": "Joseph C. Papa",
    "social_media": {
        "twitter": "https://twitter.com/BauschHealth",
        "linkedin": "https://www.linkedin.com/company/bausch-health/",
        "facebook": "https://www.facebook.com/BauschHealth/"
    },
    "investor_relations": "https://investors.bauschhealth.com",
    "key_executives": [
        {
            "name": "Joseph C. Papa",
            "position": "CEO"
        },
        {
            "name": "Paul M. Herendeen",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Dapsone Gel",
                "Xifaxan",
                "Siliq"
            ]
        },
        {
            "category": "Medical Devices",
            "products": [
                "Bausch + Lomb Contact Lenses",
                "Surgical Instruments"
            ]
        }
    ],
    "seo": {
        "meta_title": "Bausch Health Companies Inc. | Advancing the Science of Health",
        "meta_description": "Explore Bausch Health Companies Inc., a global leader in healthcare solutions dedicated to improving lives through innovative products and therapies.",
        "keywords": [
            "Bausch Health",
            "Pharmaceuticals",
            "Medical Devices",
            "Healthcare Solutions",
            "Joseph C. Papa"
        ]
    },
    "faq": [
        {
            "question": "What does Bausch Health specialize in?",
            "answer": "Bausch Health specializes in pharmaceuticals and medical devices, focusing on products for dermatology, ophthalmology, and gastrointestinal health."
        },
        {
            "question": "Who is the CEO of Bausch Health?",
            "answer": "Joseph C. Papa is the CEO of Bausch Health Companies Inc."
        },
        {
            "question": "Where is Bausch Health headquartered?",
            "answer": "Bausch Health is headquartered in Laval, Quebec, Canada."
        },
        {
            "question": "What are some of Bausch Health's main products?",
            "answer": "Bausch Health's main products include Dapsone Gel, Xifaxan, and various contact lenses."
        },
        {
            "question": "When was Bausch Health founded?",
            "answer": "Bausch Health was founded in 2013."
        }
    ],
    "competitors": [
        "AGN",
        "PFE",
        "JNJ",
        "MRK"
    ],
    "related_stocks": [
        "ABBV",
        "AMGN",
        "GILD",
        "NVS"
    ]
}